Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020

Archives of Public Health

Research

Maedeh Amini¹  Rajesh Sharma²  Chinmay Jani³ 

[1] Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran;Humanities and Social Sciences, National Institute of Technology Kurukshetra, Kurukshetra, India;Mount Aubrun Hospital, Cambridge, MA, USA;Harvard Medical School, Boston, MA, USA;

关键词: Leukemia;    Incidence;    Mortality;    Mortality-to-incidence ratio;    GLOBOCAN 2020;   

DOI  :  10.1186/s13690-023-01154-8

 received in 2023-03-01, accepted in 2023-07-18,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundLeukemia contributes significantly to the global cancer burden. Due to the importance of evaluating improvements in leukemia outcomes, the current study aimed to examine the variations in mortality-to-incidence ratio (MIR) between genders and association of MIR with the health expenditures in selected countries.MethodsThe leukemia incidence and mortality rates were extracted from the GLOBOCAN 2020 database. In total, 56 countries were included based on the data quality reports and the exclusion of missing data. The associations of MIR and changes in MIR over time (δ\documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{mathrsfs}\usepackage{upgreek}\setlength{\oddsidemargin}{-69pt}\begin{document}$$\updelta$$\end{document}MIR) with the human development index (HDI), current health expenditure (CHE) per capita, and current health expenditure as a percentage of gross domestic product (CHE/GDP) were investigated using Spearman’s rank correlation coefficient.ResultsIn 2020, an estimated 474,519 new cases of leukemia were diagnosed globally, and 311,594 deaths occurred due to the disease. Male patients exhibited a higher incidence and mortality of leukemia compared to females on a global scale. Our analysis revealed that the MIRs were the highest and lowest in Egypt (0.79) and the United States (0.29), respectively. Remarkably, countries with greater HDI, higher CHE per capita, and a higher CHE/GDP tended to have lower MIR in both genders and within gender-specific subgroups. The δMIR demonstrated a significant negative correlation with HDI and CHE per capita, whereas no significant associations were observed among female patients for CHE/GDP. Besides, all three indicators showed trends towards negative correlations with δMIR among males, though these trends were not statistically significant (p>0.05).ConclusionsGenerally, leukemia MIRs tended to be most favorable (i.e., lower) in countries with high HDI and high health expenditure. The gender differences observed in leukemia outcomes may reflect the potential influence of social, material, behavioral, and biological factors.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

Fig. 1

13690_2023_1154_Article_IEq16.gif

Fig. 1

13690_2023_1154_Article_IEq14.gif

13690_2023_1154_Article_IEq13.gif

13690_2023_1154_Article_IEq12.gif

13690_2023_1154_Article_IEq18.gif

13690_2023_1154_Article_IEq11.gif

13690_2023_1154_Article_IEq10.gif

13690_2023_1154_Article_IEq17.gif

13690_2023_1154_Article_IEq8.gif

13690_2023_1154_Article_IEq7.gif

13690_2023_1154_Article_IEq6.gif

13690_2023_1154_Article_IEq5.gif

13690_2023_1154_Article_IEq2.gif

13690_2023_1154_Article_IEq1.gif

Fig. 1

Fig. 3

Fig. 1

Fig. 1